Atlas Trials

Super-Selective Intraarterial Cerebral Infusion of Cetuximab (Erbitux) for Treatment of Relapsed/Refractory GBM and AA

Clinical trial NCT01238237 · COMPLETED

Trial details

NCT number
NCT01238237
Sponsor
Northwell Health
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Glioblastoma Multiforme (GBM)ANAPLASTIC ASTROCYTOMA (AOA)GBMAnaplastic Astrocytoma
Start date
2009-12-01
Primary completion
2016-01-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.